Komal P Singh, Bruce A Cooper, Steven M Paul, Kathryn Ruddy, Amrit B Singh, Jun Chen, Keenan A Pituch, Tom E Grys, Parminder Singh, Felipe Batalini, Marilyn J Hammer, Jon D Levine, Christine Miaskowski
Objectives: To identify subgroups of patients with distinct chemotherapy-induced vomiting (CIV) profiles; determine how these subgroups differ on several demographic, clinical, and symptom characteristics; and evaluate factors associated with chemotherapy-induced nausea and CIV profiles.
Methods & variables: Data were collected on demographic, clinical, and symptom characteristics. Differences among subgroups of patients with distinct CIV profiles were evaluated using parametric and nonparametric tests.
Results: Three CIV profiles (None, Decreasing, and Increasing) were identified. Compared with the None class, Decreasing and Increasing classes were more likely to have lower household income and a higher comorbidity burden, as well as to report higher rates of dry mouth, nausea, diarrhea, depression, anxiety, sleep disturbance, morning fatigue, and pain interference.
Implications for nursing: Clinicians need to assess common and distinct risk factors for CIV and chemotherapy-induced nausea.
{"title":"Gastrointestinal and Neuropsychological Symptoms Are Associated With Distinct Vomiting Profiles in Patients Receiving Chemotherapy.","authors":"Komal P Singh, Bruce A Cooper, Steven M Paul, Kathryn Ruddy, Amrit B Singh, Jun Chen, Keenan A Pituch, Tom E Grys, Parminder Singh, Felipe Batalini, Marilyn J Hammer, Jon D Levine, Christine Miaskowski","doi":"10.1188/24.ONF.361-380","DOIUrl":"https://doi.org/10.1188/24.ONF.361-380","url":null,"abstract":"<p><strong>Objectives: </strong>To identify subgroups of patients with distinct chemotherapy-induced vomiting (CIV) profiles; determine how these subgroups differ on several demographic, clinical, and symptom characteristics; and evaluate factors associated with chemotherapy-induced nausea and CIV profiles.</p><p><strong>Sample & setting: </strong>Adult patients (N = 1,338) receiving cancer chemotherapy.</p><p><strong>Methods & variables: </strong>Data were collected on demographic, clinical, and symptom characteristics. Differences among subgroups of patients with distinct CIV profiles were evaluated using parametric and nonparametric tests.</p><p><strong>Results: </strong>Three CIV profiles (None, Decreasing, and Increasing) were identified. Compared with the None class, Decreasing and Increasing classes were more likely to have lower household income and a higher comorbidity burden, as well as to report higher rates of dry mouth, nausea, diarrhea, depression, anxiety, sleep disturbance, morning fatigue, and pain interference.</p><p><strong>Implications for nursing: </strong>Clinicians need to assess common and distinct risk factors for CIV and chemotherapy-induced nausea.</p>","PeriodicalId":19549,"journal":{"name":"Oncology nursing forum","volume":"51 4","pages":"361-380"},"PeriodicalIF":1.6,"publicationDate":"2024-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141477149","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Tara S Davis, Theresa A Koleck, Margaret Q Rosenzweig, Christine Miaskowski, Kirk I Erickson, Susan M Sereika, Catherine M Bender, Yvette P Conley
Objectives: To explore genes in the nuclear factor E2-related factor 2 antioxidative response elements (Nrf2-ARE) signaling pathway using a multiomics approach for associations with variability of cancer-related fatigue (CRF) in postmenopausal women with early-stage hormone receptor-positive breast cancer.
Sample & setting: Postmenopausal women (N = 116) with early-stage hormone receptor-positive breast cancer were recruited from western Pennsylvania.
Methods & variables: Candidate genes from the Nrf2-ARE pathway were investigated for associations with CRF occurrence and severity. Associations were evaluated using logistic regression for occurrence and linear regression for severity.
Results: The rs2706110 TT genotype in NFE2L2 was associated with a 3.5-fold increase in odds of CRF occurrence. The cytosine-phosphate-guanine (CpG) site cg22820568 in PRDX1 was associated with CRF occurrence and severity.
Implications for nursing: Biomarkers based on Nrf2-ARE genes may help to identify women at increased risk for more severe CRF and to develop targeted interventions.
{"title":"Association Between Genes in the Nuclear Factor E2-Related Factor 2 Antioxidative Response Elements Pathway and Cancer-Related Fatigue in Women With Early-Stage Breast Cancer.","authors":"Tara S Davis, Theresa A Koleck, Margaret Q Rosenzweig, Christine Miaskowski, Kirk I Erickson, Susan M Sereika, Catherine M Bender, Yvette P Conley","doi":"10.1188/24.ONF.404-416","DOIUrl":"10.1188/24.ONF.404-416","url":null,"abstract":"<p><strong>Objectives: </strong>To explore genes in the nuclear factor E2-related factor 2 antioxidative response elements (Nrf2-ARE) signaling pathway using a multiomics approach for associations with variability of cancer-related fatigue (CRF) in postmenopausal women with early-stage hormone receptor-positive breast cancer.</p><p><strong>Sample & setting: </strong>Postmenopausal women (N = 116) with early-stage hormone receptor-positive breast cancer were recruited from western Pennsylvania.</p><p><strong>Methods & variables: </strong>Candidate genes from the Nrf2-ARE pathway were investigated for associations with CRF occurrence and severity. Associations were evaluated using logistic regression for occurrence and linear regression for severity.</p><p><strong>Results: </strong>The rs2706110 TT genotype in NFE2L2 was associated with a 3.5-fold increase in odds of CRF occurrence. The cytosine-phosphate-guanine (CpG) site cg22820568 in PRDX1 was associated with CRF occurrence and severity.</p><p><strong>Implications for nursing: </strong>Biomarkers based on Nrf2-ARE genes may help to identify women at increased risk for more severe CRF and to develop targeted interventions.</p>","PeriodicalId":19549,"journal":{"name":"Oncology nursing forum","volume":"51 4","pages":"404-416"},"PeriodicalIF":1.6,"publicationDate":"2024-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141477144","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ying Sheng, Yvette P Conley, Steven M Paul, Bruce A Cooper, Janet S Carpenter, Marilyn J Hammer, Jon D Levine, Christine Miaskowski
Objectives: To evaluate for associations between the occurrence of palpitations reported by women prior to breast cancer surgery and single nucleotide polymorphisms (SNPs) for neurotransmitter genes.
Sample & setting: A total of 398 women, who were scheduled for unilateral breast cancer surgery, provided detailed information on demographic and clinical characteristics and the occurrence of palpitations prior to breast cancer surgery.
Methods & variables: The occurrence of palpitations was assessed using a single item (i.e., "heart races/pounds" in the past week ["yes"/"no"]). Blood samples were collected for genomic analyses. Multiple logistic regression analyses were used to identify associations between the occurrence of palpitations and variations in neurotransmitter genes.
Results: Nine SNPs and two haplotypes among 11 candidate genes were associated with the occurrence of palpitations. These genes encode for a number of neurotransmitters and/or their receptors, including serotonin, norepinephrine, dopamine, gamma-amino butyric acid, Substance P, and neurokinin.
Implications for nursing: These findings suggest that alterations in a variety of neurotransmitters contribute to the development of this symptom.
{"title":"Palpitations in Women With Breast Cancer Are Associated With Polymorphisms for Neurotransmitter Genes.","authors":"Ying Sheng, Yvette P Conley, Steven M Paul, Bruce A Cooper, Janet S Carpenter, Marilyn J Hammer, Jon D Levine, Christine Miaskowski","doi":"10.1188/24.ONF.332-348","DOIUrl":"https://doi.org/10.1188/24.ONF.332-348","url":null,"abstract":"<p><strong>Objectives: </strong>To evaluate for associations between the occurrence of palpitations reported by women prior to breast cancer surgery and single nucleotide polymorphisms (SNPs) for neurotransmitter genes.</p><p><strong>Sample & setting: </strong>A total of 398 women, who were scheduled for unilateral breast cancer surgery, provided detailed information on demographic and clinical characteristics and the occurrence of palpitations prior to breast cancer surgery.</p><p><strong>Methods & variables: </strong>The occurrence of palpitations was assessed using a single item (i.e., \"heart races/pounds\" in the past week [\"yes\"/\"no\"]). Blood samples were collected for genomic analyses. Multiple logistic regression analyses were used to identify associations between the occurrence of palpitations and variations in neurotransmitter genes.</p><p><strong>Results: </strong>Nine SNPs and two haplotypes among 11 candidate genes were associated with the occurrence of palpitations. These genes encode for a number of neurotransmitters and/or their receptors, including serotonin, norepinephrine, dopamine, gamma-amino butyric acid, Substance P, and neurokinin.</p><p><strong>Implications for nursing: </strong>These findings suggest that alterations in a variety of neurotransmitters contribute to the development of this symptom.</p>","PeriodicalId":19549,"journal":{"name":"Oncology nursing forum","volume":"51 4","pages":"332-348"},"PeriodicalIF":1.6,"publicationDate":"2024-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141477151","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Susan C Grayson, Susan M Sereika, Yvette P Conley, Adrian V Lee, Steffi Oesterreich, Theresa A Koleck, Margaret Q Rosenzweig, Tiantong Liu, Susan W Wesmiller
Objectives: To phenotype the psychoneurologic (PN) symptom cluster in individuals with metastatic breast cancer and associate those phenotypes with individual characteristics and cancer genomic variables from circulating tumor DNA.
Sample & setting: This study included 201 individuals with metastatic breast cancer recruited in western Pennsylvania.
Methods & variables: A descriptive, cross-sectional design was used. Symptom data were collected via the MD Anderson Symptom Inventory, and cancer genomic data were collected via ultra-low-pass whole-genome sequencing of circulating tumor DNA from participant blood.
Results: Three distinct PN symptom phenotypes were described in a population with metastatic breast cancer: mild symptoms, moderate symptoms, and severe mood-related symptoms. Breast cancer TP53 deletion was significantly associated with membership in a moderate to severe symptoms phenotype (p = 0.013).
Implications for nursing: Specific cancer genomic changes associated with increased genomic instability may be predictive of PN symptoms. This finding may enable proactive treatment or reveal new therapeutic targets for symptom management.
目标:对转移性乳腺癌患者的精神神经症状群进行表型分析,并将这些表型与个体特征和来自循环肿瘤 DNA 的癌症基因组变量联系起来:对转移性乳腺癌患者的精神神经症状群(PN)进行表型,并将这些表型与循环肿瘤DNA中的个体特征和癌症基因组变量联系起来:本研究包括在宾夕法尼亚州西部招募的 201 名转移性乳腺癌患者:采用描述性横断面设计。症状数据通过 MD 安德森症状量表收集,癌症基因组数据通过对参与者血液中的循环肿瘤 DNA 进行超低通量全基因组测序收集:结果:在转移性乳腺癌患者中发现了三种不同的 PN 症状表型:轻度症状、中度症状和严重的情绪相关症状。乳腺癌 TP53 基因缺失与中度至重度症状表型显著相关(p = 0.013):对护理工作的启示:与基因组不稳定性增加相关的特定癌症基因组变化可能是 PN 症状的预测因素。这一发现可能有助于积极治疗或揭示症状控制的新治疗靶点。
{"title":"The Psychoneurologic Symptom Cluster and Its Association With Breast Cancer Genomic Instability.","authors":"Susan C Grayson, Susan M Sereika, Yvette P Conley, Adrian V Lee, Steffi Oesterreich, Theresa A Koleck, Margaret Q Rosenzweig, Tiantong Liu, Susan W Wesmiller","doi":"10.1188/24.ONF.391-403","DOIUrl":"https://doi.org/10.1188/24.ONF.391-403","url":null,"abstract":"<p><strong>Objectives: </strong>To phenotype the psychoneurologic (PN) symptom cluster in individuals with metastatic breast cancer and associate those phenotypes with individual characteristics and cancer genomic variables from circulating tumor DNA.</p><p><strong>Sample & setting: </strong>This study included 201 individuals with metastatic breast cancer recruited in western Pennsylvania.</p><p><strong>Methods & variables: </strong>A descriptive, cross-sectional design was used. Symptom data were collected via the MD Anderson Symptom Inventory, and cancer genomic data were collected via ultra-low-pass whole-genome sequencing of circulating tumor DNA from participant blood.</p><p><strong>Results: </strong>Three distinct PN symptom phenotypes were described in a population with metastatic breast cancer: mild symptoms, moderate symptoms, and severe mood-related symptoms. Breast cancer TP53 deletion was significantly associated with membership in a moderate to severe symptoms phenotype (p = 0.013).</p><p><strong>Implications for nursing: </strong>Specific cancer genomic changes associated with increased genomic instability may be predictive of PN symptoms. This finding may enable proactive treatment or reveal new therapeutic targets for symptom management.</p>","PeriodicalId":19549,"journal":{"name":"Oncology nursing forum","volume":"51 4","pages":"391-403"},"PeriodicalIF":1.6,"publicationDate":"2024-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141477082","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The position statement on fertility preservation was produced through collaborative efforts among the Association of Pediatric Hematology/Oncology Nurses, Canadian Association of Nurses in Oncology/Association canadienne des.
{"title":"Fertility Preservation in Individuals With Cancer.","authors":"","doi":"10.1188/24.ONF.294-296","DOIUrl":"https://doi.org/10.1188/24.ONF.294-296","url":null,"abstract":"<p><p>The position statement on fertility preservation was produced through collaborative efforts among the Association of Pediatric Hematology/Oncology Nurses, Canadian Association of Nurses in Oncology/Association canadienne des.</p>","PeriodicalId":19549,"journal":{"name":"Oncology nursing forum","volume":"51 4","pages":"294-296"},"PeriodicalIF":1.6,"publicationDate":"2024-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141477148","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Joosun Shin, Marilyn J Hammer, Mary E Cooley, Bruce A Cooper, Steven M Paul, Yvette P Conley, Kord M Kober, Jon D Levine, Christine Miaskowski
Objectives: To identify subgroups of patients with distinct cough occurrence profiles and evaluate for differences among these subgroups.
Sample & setting: Outpatients receiving chemotherapy (N = 1,338) completed questionnaires six times over two chemotherapy cycles.
Methods & variables: Occurrence of cough was assessed using the Memorial Symptom Assessment Scale. Latent class analysis was used to identify subgroups with distinct cough occurrence profiles. Parametric and nonparametric tests were used to evaluate for differences.
Results: Four distinct cough profiles were identified (None, Decreasing, Increasing, and High). Risk factors associated with membership in the High class included lower annual household income; history of smoking; self-reported diagnoses of lung disease, heart disease, and back pain; and having lung cancer.
Implications for nursing: Clinicians need to assess all patients with cancer for cough and provide targeted interventions.
{"title":"Lower Income, Smoking, Cardiopulmonary Comorbidities, and Higher Symptom Burden Influence the Occurrence of Cough in Patients Receiving Chemotherapy.","authors":"Joosun Shin, Marilyn J Hammer, Mary E Cooley, Bruce A Cooper, Steven M Paul, Yvette P Conley, Kord M Kober, Jon D Levine, Christine Miaskowski","doi":"10.1188/24.ONF.E4-E24","DOIUrl":"https://doi.org/10.1188/24.ONF.E4-E24","url":null,"abstract":"<p><strong>Objectives: </strong>To identify subgroups of patients with distinct cough occurrence profiles and evaluate for differences among these subgroups.</p><p><strong>Sample & setting: </strong>Outpatients receiving chemotherapy (N = 1,338) completed questionnaires six times over two chemotherapy cycles.</p><p><strong>Methods & variables: </strong>Occurrence of cough was assessed using the Memorial Symptom Assessment Scale. Latent class analysis was used to identify subgroups with distinct cough occurrence profiles. Parametric and nonparametric tests were used to evaluate for differences.</p><p><strong>Results: </strong>Four distinct cough profiles were identified (None, Decreasing, Increasing, and High). Risk factors associated with membership in the High class included lower annual household income; history of smoking; self-reported diagnoses of lung disease, heart disease, and back pain; and having lung cancer.</p><p><strong>Implications for nursing: </strong>Clinicians need to assess all patients with cancer for cough and provide targeted interventions.</p>","PeriodicalId":19549,"journal":{"name":"Oncology nursing forum","volume":"51 4","pages":"E4-E24"},"PeriodicalIF":1.6,"publicationDate":"2024-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141477150","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Robert D Siegel, Kristine B LeFebvre, Sarah Temin, Amy Evers, Lisa Barbarotta, Ronda M Bowman, Alexandre Chan, David W Dougherty, Michael Ganio, Therese Marie Mulvey, Amanda Ouzts, Martha Polovich, Maritza Salazar-Abshire, Elaine Stenstrup, Christine Marie Sydenstricker, Susan Tsai, MiKaela Olsen
Purpose: To update the American Society of Clinical Oncology (ASCO)-Oncology Nursing Society (ONS) standards for antineoplastic therapy administration safety in adult and pediatric oncology and highlight current standards for antineoplastic therapy for adult and pediatric populations with various routes of administration and location.
Methods: ASCO and ONS convened a multidisciplinary Expert Panel with representation of multiple organizations to conduct literature reviews and add to the standards as needed. The evidence base was combined with the opinion of the ASCO-ONS Expert Panel to develop antineoplastic safety standards and guidance. Public comments were solicited and considered in preparation of the final manuscript.
Results: The standards presented here include clarification and expansion of existing standards to include home administration and other changes in processes of ordering, preparing, and administering antineoplastic therapy; the advent of immune effector cellular therapy; the importance of social determinants of health; fertility preservation; and pregnancy avoidance. In addition, the standards have added a fourth verification.
Standards: Standards are provided for which health care organizations and those involved in all aspects of patient care can safely deliver antineoplastic therapy, increase the quality of care, and reduce medical errors.
目的:更新美国临床肿瘤学会(ASCO)-肿瘤护理学会(ONS)关于成人和儿童肿瘤抗肿瘤治疗用药安全性的标准,并强调成人和儿童抗肿瘤治疗不同给药途径和部位的现行标准:方法:ASCO 和 ONS 召集了一个由多个组织代表组成的多学科专家小组,对文献进行审查,并根据需要对标准进行补充。证据基础与 ASCO-ONS 专家小组的意见相结合,制定了抗肿瘤安全性标准和指南。在编写最终稿件时,还征求并考虑了公众意见:结果:本文介绍的标准包括对现有标准的澄清和扩展,以纳入家庭管理以及抗肿瘤治疗的订购、准备和实施过程中的其他变化;免疫效应细胞疗法的出现;健康的社会决定因素的重要性;生育力保护;以及避免妊娠。此外,标准还增加了第四项核查:标准:提供了医疗机构和参与患者护理各方面工作的人员可以安全提供抗肿瘤治疗、提高护理质量和减少医疗差错的标准。
{"title":"Antineoplastic Therapy Administration Safety Standards for Adult and Pediatric Oncology: ASCO-ONS Standards.","authors":"Robert D Siegel, Kristine B LeFebvre, Sarah Temin, Amy Evers, Lisa Barbarotta, Ronda M Bowman, Alexandre Chan, David W Dougherty, Michael Ganio, Therese Marie Mulvey, Amanda Ouzts, Martha Polovich, Maritza Salazar-Abshire, Elaine Stenstrup, Christine Marie Sydenstricker, Susan Tsai, MiKaela Olsen","doi":"10.1188/24.ONF.297-320","DOIUrl":"10.1188/24.ONF.297-320","url":null,"abstract":"<p><strong>Purpose: </strong>To update the American Society of Clinical Oncology (ASCO)-Oncology Nursing Society (ONS) standards for antineoplastic therapy administration safety in adult and pediatric oncology and highlight current standards for antineoplastic therapy for adult and pediatric populations with various routes of administration and location.</p><p><strong>Methods: </strong>ASCO and ONS convened a multidisciplinary Expert Panel with representation of multiple organizations to conduct literature reviews and add to the standards as needed. The evidence base was combined with the opinion of the ASCO-ONS Expert Panel to develop antineoplastic safety standards and guidance. Public comments were solicited and considered in preparation of the final manuscript.</p><p><strong>Results: </strong>The standards presented here include clarification and expansion of existing standards to include home administration and other changes in processes of ordering, preparing, and administering antineoplastic therapy; the advent of immune effector cellular therapy; the importance of social determinants of health; fertility preservation; and pregnancy avoidance. In addition, the standards have added a fourth verification.</p><p><strong>Standards: </strong>Standards are provided for which health care organizations and those involved in all aspects of patient care can safely deliver antineoplastic therapy, increase the quality of care, and reduce medical errors.</p>","PeriodicalId":19549,"journal":{"name":"Oncology nursing forum","volume":"51 4","pages":"297-320"},"PeriodicalIF":1.6,"publicationDate":"2024-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141477143","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Lisa R Bailey, Melissa Craft, Shannon S C Bert, Barbara W Carlson
Purpose: To explore the impact of disruptions in information processing (DIPs) on social roles, well-being, and quality of life (QOL) in breast cancer survivors after chemotherapy.
Participants & setting: Experiences of DIPs were explored in eight breast cancer survivors aged 53-70 years, 12-60 months post-treatment, referred from a National Cancer Institute-designated cancer center and a nonprofit breast cancer support organization from January 6 to August 31, 2020.
Methodologic approach: This study used a mixed-methods approach. Participants journaled and answered questionnaires sent via mail that asked them about changes in their cognition, QOL, and social roles. Qualitative data were thematically analyzed using constant comparative analysis, and questionnaire scores were compared with qualitative data.
Findings: Journals revealed problems with functioning in occupational roles and increased stress, anxiety, and frustration. Women with more DIPs tended to have lower role satisfaction and QOL. Greater role satisfaction was associated with higher QOL and social role participation.
Implications for nursing: Mitigating the effects of DIPs on social function may allow women to continue in important roles, which has the potential to affect QOL.
{"title":"The Impact of Chemotherapy-Related Cognitive Impairment on Social Roles and Well-Being in Breast Cancer Survivors.","authors":"Lisa R Bailey, Melissa Craft, Shannon S C Bert, Barbara W Carlson","doi":"10.1188/24.ONF.153-162","DOIUrl":"10.1188/24.ONF.153-162","url":null,"abstract":"<p><strong>Purpose: </strong>To explore the impact of disruptions in information processing (DIPs) on social roles, well-being, and quality of life (QOL) in breast cancer survivors after chemotherapy.</p><p><strong>Participants & setting: </strong>Experiences of DIPs were explored in eight breast cancer survivors aged 53-70 years, 12-60 months post-treatment, referred from a National Cancer Institute-designated cancer center and a nonprofit breast cancer support organization from January 6 to August 31, 2020.</p><p><strong>Methodologic approach: </strong>This study used a mixed-methods approach. Participants journaled and answered questionnaires sent via mail that asked them about changes in their cognition, QOL, and social roles. Qualitative data were thematically analyzed using constant comparative analysis, and questionnaire scores were compared with qualitative data.</p><p><strong>Findings: </strong>Journals revealed problems with functioning in occupational roles and increased stress, anxiety, and frustration. Women with more DIPs tended to have lower role satisfaction and QOL. Greater role satisfaction was associated with higher QOL and social role participation.</p><p><strong>Implications for nursing: </strong>Mitigating the effects of DIPs on social function may allow women to continue in important roles, which has the potential to affect QOL.</p>","PeriodicalId":19549,"journal":{"name":"Oncology nursing forum","volume":"51 2","pages":"153-162"},"PeriodicalIF":1.9,"publicationDate":"2024-02-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140040052","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Each abstract has been indexed according to first author. Abstracts appear as they were submitted and have not undergone editing or the Oncology Nursing Forum's review process. Only abstracts that will be presented appear h.
{"title":"2024 ONS Congress® Poster Abstracts.","authors":"","doi":"10.1188/24.ONF.E2","DOIUrl":"10.1188/24.ONF.E2","url":null,"abstract":"<p><p>Each abstract has been indexed according to first author. Abstracts appear as they were submitted and have not undergone editing or the Oncology Nursing Forum's review process. Only abstracts that will be presented appear h.</p>","PeriodicalId":19549,"journal":{"name":"Oncology nursing forum","volume":"51 2","pages":"E2"},"PeriodicalIF":1.9,"publicationDate":"2024-02-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140040046","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Timiya S Nolan, Jennifer A Sinnott, Jessica L Krok-Schoen, Elizabeth K Arthur, Emily Ridgway-Limle, Darrell M Gray Ii, Daniel Addison, Sakima Smith, Karen Patricia Williams, Darryl B Hood, Joshua J Joseph, Ashley Felix
Objectives: To examine if racial differences in cardiovascular health (CVH) are associated with cardiovascular disease (CVD) disparities among women with breast and gynecologic cancers.
Sample & setting: The sample consisted of 252 Black women and 93 White women without a self-reported history of cancer or CVD who developed a breast or gynecologic malignancy. Women who developed CVD before their cancer diagnosis were excluded.
Methods & variables: CVH was classified using metrics of the American Heart Association's Life's Simple 7 framework. Metrics were summed to create a total CVH score (0-7). Associations among race, ideal CVH (score of 5-7), and CVD incidence following cancer diagnosis were estimated with Cox proportional hazards models.
Results: Ideal CVH was similar between Black women (33%) and White women (37%). Race and CVH were not associated with CVD incidence.
Implications for nursing: In a small sample of women diagnosed with breast and gynecologic cancers, racial disparities in CVH and CVD incidence were not observed. Additional investigation of potential confounders relating to social determinants of health tied to the construct of race is warranted.
{"title":"Cardiovascular Disease Incidence and Cardiovascular Health Among Diverse Women With Breast and Gynecologic Cancers.","authors":"Timiya S Nolan, Jennifer A Sinnott, Jessica L Krok-Schoen, Elizabeth K Arthur, Emily Ridgway-Limle, Darrell M Gray Ii, Daniel Addison, Sakima Smith, Karen Patricia Williams, Darryl B Hood, Joshua J Joseph, Ashley Felix","doi":"10.1188/24.ONF.113-125","DOIUrl":"10.1188/24.ONF.113-125","url":null,"abstract":"<p><strong>Objectives: </strong>To examine if racial differences in cardiovascular health (CVH) are associated with cardiovascular disease (CVD) disparities among women with breast and gynecologic cancers.</p><p><strong>Sample & setting: </strong>The sample consisted of 252 Black women and 93 White women without a self-reported history of cancer or CVD who developed a breast or gynecologic malignancy. Women who developed CVD before their cancer diagnosis were excluded.</p><p><strong>Methods & variables: </strong>CVH was classified using metrics of the American Heart Association's Life's Simple 7 framework. Metrics were summed to create a total CVH score (0-7). Associations among race, ideal CVH (score of 5-7), and CVD incidence following cancer diagnosis were estimated with Cox proportional hazards models.</p><p><strong>Results: </strong>Ideal CVH was similar between Black women (33%) and White women (37%). Race and CVH were not associated with CVD incidence.</p><p><strong>Implications for nursing: </strong>In a small sample of women diagnosed with breast and gynecologic cancers, racial disparities in CVH and CVD incidence were not observed. Additional investigation of potential confounders relating to social determinants of health tied to the construct of race is warranted.</p>","PeriodicalId":19549,"journal":{"name":"Oncology nursing forum","volume":"51 2","pages":"113-125"},"PeriodicalIF":1.6,"publicationDate":"2024-02-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11350631/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140040048","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}